Samuel D. Colella

Insider Reports History

Entity
Individual
Location
One Sansome Street, Suite 3630, San Francisco, CA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel D. Colella:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By Colella Partners
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By Colella Partners II
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By spouse
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By the Colella Family Exempt Marital Deduction Trust
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By the Colella Family Trust
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By Versant Development Fund III, LLC
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By Versant Side Fund III
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 By Versant Venture Capital III L.P.
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 The Samuel Colella Trust
Flexion Therapeutics Inc Director Stock option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Samuel D. Colella

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FLXN Flexion Therapeutics Inc Nov 19, 2021 18 -$12.7M 4 Nov 19, 2021 Director
FLXN Flexion Therapeutics Inc Jun 24, 2021 2 $0 4 Jun 28, 2021 Director